HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

V Z Lankin Selected Research

Lipid Peroxides

1/2009[Antioxidant status and restenosis after stenting of coronary arteries].
7/2005Oxidative stress in atherosclerosis and diabetes.
2/2005Low daily dose of antioxidant probucol decreases incidence and severity of restenosis after transluminal coronary balloon angioplasty.
8/2003Complex of vitamins and antioxidants protects low-density lipoproteins in blood plasma from free radical oxidation and activates antioxidants enzymes in erythrocytes from patients with coronary heart disease.
7/2002Intensification of free radical oxidation of low-density lipoproteins in the plasma of patients with ischemic heart disease receiving beta-hydroxy-beta-methylglutaryl-coenzyme A reductase inhibitor cerivastatin and inhibition of low-density lipoprotein peroxidation with antioxidant probucol.
10/2000Trimetazidine as indirect antioxidant.
7/2000Beta-carotene-containing preparation carinat inhibits lipid peroxidation and development of renal tumors in rats treated with chemical carcinogen.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


V Z Lankin Research Topics

Disease

8Coronary Disease (Coronary Heart Disease)
01/2021 - 10/2000
7Myocardial Ischemia (Ischemic Heart Diseases)
06/2020 - 02/2000
7Atherosclerosis
03/2019 - 02/2003
6Diabetes Mellitus
03/2019 - 08/2003
5Ischemia
06/2022 - 10/2000
5Type 2 Diabetes Mellitus (MODY)
11/2018 - 07/2005
5Hypercholesterolemia
04/2007 - 07/2002
2Cardiovascular Diseases (Cardiovascular Disease)
01/2015 - 01/2014
2Hypertension (High Blood Pressure)
01/2015 - 01/2006
2Infarction (Infarctions)
06/2014 - 01/2013
2Familial Primary Pulmonary Hypertension
01/2005 - 06/2002
1Myocardial Infarction
06/2022
1Cardiomyopathies (Cardiomyopathy)
01/2020
1Coronary Artery Disease (Coronary Atherosclerosis)
09/2018
1Pathologic Constriction (Stenosis)
01/2009
1Coronary Stenosis (Coronary Artery Stenosis)
11/2007
1Heart Failure
02/2007
1Hypertrophy
01/2006
1Body Weight (Weight, Body)
05/2004
1Hyperlipoproteinemia Type II (Familial Hypercholesterolemia)
07/2003
1Pulmonary Hypertension
06/2002
1Hepatocellular Carcinoma (Hepatoma)
11/2000
1Neoplasms (Cancer)
07/2000

Drug/Important Bio-Agent (IBA)

20AntioxidantsIBA
06/2022 - 03/2000
15Free RadicalsIBA
06/2022 - 02/2000
12LDL Lipoproteins (beta Lipoproteins)IBA
06/2022 - 02/2000
11oxidized low density lipoproteinIBA
06/2022 - 07/2003
11EnzymesIBA
01/2020 - 10/2000
7Lipid PeroxidesIBA
01/2009 - 07/2000
6Glutathione PeroxidaseIBA
09/2018 - 03/2000
4Superoxide Dismutase-1IBA
06/2020 - 11/2012
4CatalaseIBA
09/2018 - 11/2000
4LipidsIBA
01/2015 - 07/2003
4Probucol (Lorelco)FDA Link
11/2007 - 07/2002
3Peptides (Polypeptides)IBA
06/2022 - 01/2013
3L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA
06/2022 - 01/2013
3Biomarkers (Surrogate Marker)IBA
01/2021 - 08/2010
3Glucose (Dextrose)FDA LinkGeneric
01/2015 - 07/2005
3Reactive Oxygen Species (Oxygen Radicals)IBA
06/2014 - 11/2000
3Pyruvaldehyde (Methylglyoxal)IBA
11/2012 - 08/2010
3CholesterolIBA
08/2010 - 07/2002
3VitaminsIBA
01/2004 - 02/2003
3SeleniumIBA
08/2003 - 03/2000
2MB Form Creatine KinaseIBA
06/2022 - 06/2014
2apelin-12 peptideIBA
06/2014 - 01/2013
2hydroxide ionIBA
06/2014 - 01/2013
2arginylprolineIBA
06/2014 - 01/2013
2seryl-histidineIBA
06/2014 - 01/2013
2lysylglycineIBA
06/2014 - 01/2013
2Malondialdehyde (Propanedial)IBA
06/2014 - 11/2012
2Glyoxal (Ethanedial)IBA
11/2012 - 08/2010
2Metformin (Glucophage)FDA LinkGeneric
05/2012 - 02/2007
2Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
04/2007 - 07/2002
2UbiquinoneIBA
01/2006 - 05/2004
2CopperIBA
01/2004 - 07/2003
2coenzyme Q10 (CoQ10)IBA
07/2002 - 02/2000
1DipeptidesIBA
06/2022
1Type 2 Galanin ReceptorIBA
06/2022
1CarnosineIBA
06/2022
11-nitrohydroxyphenyl-N-benzoylalanine (GAL 1)IBA
06/2022
1Indicators and Reagents (Reagents)IBA
06/2020
1Galanin Receptors (Galanin Receptor)IBA
01/2020
1PeroxiredoxinsIBA
03/2019
1Proteins (Proteins, Gene)FDA Link
11/2018
1Biopolymers (Biopolymer)IBA
11/2018
1Nucleic AcidsIBA
11/2018
1FructoseIBA
01/2015
1CarbohydratesIBA
01/2015
1KetosesIBA
01/2015
1IsoenzymesIBA
06/2014
15,5-dimethyl-1-pyrroline-1-oxideIBA
06/2014
1Hydroxyl RadicalIBA
06/2014
13-(2,2,2-trimethylhydrazine)propionateIBA
01/2014
1Creatine Kinase (Creatine Phosphokinase)IBA
01/2013
1Glutathione Transferase (Glutathione S-Transferase)IBA
11/2012
1Pharmaceutical PreparationsIBA
05/2012
1SugarsIBA
05/2012
1Superoxides (Superoxide)IBA
05/2012
1LDL CholesterolIBA
08/2010
1Biological ProductsIBA
04/2007
1Glyburide (Glibenclamide)FDA LinkGeneric
02/2007
1diabetonIBA
02/2007
1N 30IBA
02/2007
1Drinking WaterIBA
01/2006
1AldehydesIBA
07/2005
1Carvedilol (Coreg)FDA LinkGeneric
01/2005
1Hypoglycemic Agents (Hypoglycemics)IBA
08/2003
1ProvitaminsIBA
08/2003
1ElementsIBA
08/2003
1Coenzyme A (CoA)IBA
07/2002
1cerivastatin (Kazak)FDA Link
07/2002
1Oxidoreductases (Dehydrogenase)IBA
07/2002
1XenobioticsIBA
11/2000
1pyreneIBA
11/2000
1Trimetazidine (Vastarel)IBA
10/2000
1CarcinogensIBA
07/2000

Therapy/Procedure

9Therapeutics
12/2016 - 10/2000
2Intravenous Administration
06/2022 - 01/2013
1Stents
01/2009
1Glycemic Control
02/2007